中文

苏州规划 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-24
ItemAmountY/Y
Revenue¥0.04B-13.9%
Gross profit¥0.01B
Operating income¥0.00B
Net income¥0.00B-21.2%
Gross margin24.9%Net margin 6.3%
Revenue Q/Q-60.3%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.03B75.1%
R&D¥0.00B10.5%
SG&A¥0.01B25.2%
Tax & other¥-0.00B-0.1%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

民生健康中机认检金凯生科固高科技德福科技智信精密尚水智能港通医疗中远通陕西华达长华化学舜禹股份

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies